Drospirenone and estradiol: a new option for the postmenopausal woman.
about
Progestogen safety and tolerance in hormonal replacement therapy.Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats.Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review.Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women.Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
P2860
Drospirenone and estradiol: a new option for the postmenopausal woman.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Drospirenone and estradiol: a new option for the postmenopausal woman.
@ast
Drospirenone and estradiol: a new option for the postmenopausal woman.
@en
type
label
Drospirenone and estradiol: a new option for the postmenopausal woman.
@ast
Drospirenone and estradiol: a new option for the postmenopausal woman.
@en
prefLabel
Drospirenone and estradiol: a new option for the postmenopausal woman.
@ast
Drospirenone and estradiol: a new option for the postmenopausal woman.
@en
P2860
P3181
P1433
P1476
Drospirenone and estradiol: a new option for the postmenopausal woman.
@en
P2093
P2860
P356
10.1080/13697130601114859
P478
10 Suppl 1
P577
2007-02-01T00:00:00Z